Medical Excellence Capital
Overview
Medical Excellence Capital (MEC) is an early-stage venture capital firm focused on the life sciences and healthcare industry . MEC provides company creation, seed, and early-stage capital to innovators in precision medicine such as cell therapy, gene therapy, AI/ML applied to drug discovery, synthetic biology, and regenerative medicine . MEC invests solely in high-potential companies where its expertise, insights, and global network can promote acceleration and maximized value creation .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aspen Neuroscience | Nov 2025 | Series C | Co-investor |
| Ladder Bio | Nov 2025 | Seed | Lead |
| PLENO | Dec 2024 | Series B | Co-investor |
| Pleno | Dec 2024 | Series B | Co-investor |
| GCTx | Sep 2024 | Series A | - |
Key People
Brian Halak
Managing Partner
Eric Heil
Managing Partner
Joni Mancini
Managing Partner
Kim Kamdar
Managing Partner
Muhamad Furqon
Commercial Investment Partner Senior Partner, Audit And Risk Committee(semi-retired)
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.